Pharmaceutical

FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine 

The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused trials.

Nov 13, 2024 - 06:00
FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine 
The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused trials.
Read the original article

Tags:

Previous Article

Pfizer considers divestiture of hospital drugs business

Next Article

NHS launches “game-changer” and lifesaving anti-smoking pill

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Startup launches with $245 million for twice yearly asthma treatment

STAT+: Startup launches with $245 million for twice yea...

Oct 24, 2023

La ‘paradoja hispana’ intriga a una nueva generación de investigadores decididos a resolverla

La ‘paradoja hispana’ intriga a una nueva generación de...

Nov 1, 2023

Mankind Pharma acquires Bharat Serums and Vaccines for $1.6bn

Mankind Pharma acquires Bharat Serums and Vaccines for ...

Jul 28, 2024